243 related articles for article (PubMed ID: 15135980)
1. Sub-clinical infection as an effective protocol for obtaining anti-Leishmania chagasi amastigote antibodies of different animal species.
Fróes AM; dos Santos CV; Penha-Filho ML; Teixeira MC; Correa Silva TM; Oliveira GG; dos Santos WL; Pontes-de-Carvalho LC; Alcântara-Neves NM
Vet Immunol Immunopathol; 2004 Jun; 99(3-4):135-41. PubMed ID: 15135980
[TBL] [Abstract][Full Text] [Related]
2. A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi as an antigen for delayed-type hypersensitivity assays and serodiagnosis of canine visceral leishmaniasis.
Pinheiro PH; Pinheiro AN; Ferreira JH; Costa FA; Katz S; Barbiéri CL
Vet Parasitol; 2009 May; 162(1-2):32-9. PubMed ID: 19269098
[TBL] [Abstract][Full Text] [Related]
3. Exacerbation of Leishmania (Viannia) shawi infection in BALB/c mice after immunization with soluble antigen from amastigote forms.
Passero LF; Da Costa Bordon ML; De Carvalho AK; Martins LM; Corbett CE; Laurenti MD
APMIS; 2010 Dec; 118(12):973-81. PubMed ID: 21091779
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum.
Bras-Gonçalves R; Petitdidier E; Pagniez J; Veyrier R; Cibrelus P; Cavaleyra M; Maquaire S; Moreaux J; Lemesre JL
Infect Genet Evol; 2014 Jun; 24():1-14. PubMed ID: 24614507
[TBL] [Abstract][Full Text] [Related]
5. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry.
Silvestre R; Santarém N; Cunha J; Cardoso L; Nieto J; Carrillo E; Moreno J; Cordeiro-da-Silva A
Vet Parasitol; 2008 Nov; 158(1-2):23-30. PubMed ID: 18848397
[TBL] [Abstract][Full Text] [Related]
6. Effects of anti-Leishmania monoclonal antibodies on the development of Leishmania major in Phlebotomus duboscqi (Diptera: Psychodidae).
Anjili C; Langat B; Ngumbi P; Mbati PA; Githure J; Tonui WK
East Afr Med J; 2006 Feb; 83(2):72-8. PubMed ID: 16708877
[TBL] [Abstract][Full Text] [Related]
7. Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.
Ferreira JH; Gentil LG; Dias SS; Fedeli CE; Katz S; Barbiéri CL
Vaccine; 2008 Jan; 26(5):677-85. PubMed ID: 18160187
[TBL] [Abstract][Full Text] [Related]
8. Montenegro's skin reactions and antibodies against different Leishmania species in dogs from a visceral leishmaniosis endemic area.
Baleeiro CO; Paranhos-Silva M; dos Santos JC; Oliveira GG; Nascimento EG; de Carvalho LP; dos-Santos WL
Vet Parasitol; 2006 Jun; 139(1-3):21-8. PubMed ID: 16567046
[TBL] [Abstract][Full Text] [Related]
9. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
10. Leishmania amazonensis: humoral response to amastigote excreted-antigens in murine leishmaniasis.
Hernández-Chinea C
Exp Parasitol; 2007 Aug; 116(4):492-6. PubMed ID: 17349625
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis.
Fujiwara RT; Vale AM; França da Silva JC; da Costa RT; Quetz Jda S; Martins Filho OA; Reis AB; Corrêa Oliveira R; Machado-Coelho GL; Bueno LL; Bethony JM; Frank G; Nascimento E; Genaro O; Mayrink W; Reed S; Campos-Neto A
Vet Res; 2005; 36(5-6):827-38. PubMed ID: 16120256
[TBL] [Abstract][Full Text] [Related]
12. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
[TBL] [Abstract][Full Text] [Related]
13. Use of ELISA employing Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens for the detection of IgG and IgG1 and IgG2 subclasses in the diagnosis of American tegumentary leishmaniasis in dogs.
Ribeiro FC; de O Schubach A; Mouta-Confort E; Schubach TM; de Fátima Madeira M; Marzochi MC
Vet Parasitol; 2007 Sep; 148(3-4):200-6. PubMed ID: 17689193
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants.
Pan AA; McMahon-Pratt D
J Immunol; 1988 Apr; 140(7):2406-14. PubMed ID: 2450920
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of anti-Leishmania (Leishmania) chagasi IgG titers detected by flow cytometry to distinguish infected from vaccinated dogs.
de Andrade RA; Reis AB; Gontijo CM; Braga LB; Rocha RD; Araújo MS; Vianna LR; Martins-Filho OA
Vet Immunol Immunopathol; 2007 Mar; 116(1-2):85-97. PubMed ID: 17287029
[TBL] [Abstract][Full Text] [Related]
16. Leishmania amazonensis: cultivation and characterization of axenic amastigote-like organisms.
Hodgkinson VH; Soong L; Duboise SM; McMahon-Pratt D
Exp Parasitol; 1996 Jun; 83(1):94-105. PubMed ID: 8654556
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood mononuclear cell supernatants from asymptomatic dogs immunized and experimentally challenged with Leishmania chagasi can stimulate canine macrophages to reduce infection in vitro.
Rodrigues CA; Batista LF; Teixeira MC; Pereira AM; Santos PO; de Sá Oliveira GG; de Freitas LA; Veras PS
Vet Parasitol; 2007 Feb; 143(3-4):197-205. PubMed ID: 17045743
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.
Liew FY; Hale C; Howard JG
J Immunol; 1985 Sep; 135(3):2095-101. PubMed ID: 4020140
[TBL] [Abstract][Full Text] [Related]
19. A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania species.
Teixeira MC; de Jesus Santos R; Sampaio RB; Pontes-de-Carvalho L; dos-Santos WL
Parasitol Res; 2002 Nov; 88(11):963-8. PubMed ID: 12375160
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.
Calvopina M; Barroso PA; Marco JD; Korenaga M; Cooper PJ; Nonaka S; Hashiguchi Y
Vaccine; 2006 Jul; 24(27-28):5645-52. PubMed ID: 16621179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
